|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
HIV VACCINES: Design - Potency - Delivery* | ||||||||||||||||
February 27, 2003 | ||||||||||||||||
The Knowledge Foundation, Inc., Cambridge, MA USA June 22 - 23, 2003 Detailed agenda available at website. The CDC has reported that 30 million people are infected worldwide with HIV. Even though this epidemic continues to grow, there is no vaccine available which can be used on its own for treatment or prevention of the HIV infection. Progressive treatment of this condition relies greatly on researchers targeting such issues as improving the immunogenicity of current vaccines, designing an effective delivery tool, finding vaccines for the HIV strain variation and boosting the humoral and cellular immunity. Increasing the Potency of DNA Vaccines Pre-Conference Workshop Immuno Assays: |
||||||||||||||||
Organized by: | The Knowledge Foundation, Inc. | |||||||||||||||
Invited Speakers: | M. Caulfield, Merck D. Chen, PowderJect Vaccines M. Cho, Case Western Reserve University A. DeGroot, Epivax A. DeVico, U. Maryland M. Egan, Wyeth Research T. Hanke, MRC J. Joyce, Merck A. Kalyuzhny, R&D Systems R. Kowalski, Cylex J. Lisziewicz, RIGHT C. Locher, Maxygen M. Newman, Epimmune G. Pavlakis, NCI C. Petropoulos, ViroLogic P. Poignard, The Scripps Research Institute E. Rabellino, Beckman Coulter R. Ruprecht, Dana Farber Cancer Institute M. Sommerfelt, Bionor Immuno J. Ulmer, Chiron C. Wang, United Biomedical D. Weiner, U. Pennsylvania
|
|||||||||||||||
Deadline for Abstracts: | none | |||||||||||||||
Registration: | online registration available at website. | |||||||||||||||
E-mail: | meder@knowledgefoundation.com | |||||||||||||||
Posted by: | Margit Eder | |||||||||||||||
Host: | 141.149.163.2 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |